Phase I trials of amonafide as monotherapy and in combination with cytarabine in patients with poor-risk acute myeloid leukemia

Capizzi, Robert L.; Allen, Steven L.; Kolitz, Jonathan E.; Lundberg, Ante S; Bennett, John M.; Budman, Daniel R

doi:10.1016/j.leukres.2009.07.038

Record: found
Abstract: not found
Article: not found

Phase I trials of amonafide as monotherapy and in combination with cytarabine in patients with poor-risk acute myeloid leukemia

Author(s): Steven L. Allen , Jonathan E. Kolitz , Ante S. Lundberg , John M. Bennett , Robert L. Capizzi , Daniel R. Budman

Publication date Created: April 2010

Publication date (Print): April 2010

Journal: Leukemia Research

Publisher: Elsevier BV

Read this article at

ScienceOpenPublisher

Bookmark

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Related collections

Author and article information

Journal

Title: Leukemia Research

Abbreviated Title: Leukemia Research

Publisher: Elsevier BV

ISSN (Print): 01452126

Publication date Created: April 2010

Publication date (Print): April 2010

Volume: 34

Issue: 4

Pages: 487-491

Article

DOI: 10.1016/j.leukres.2009.07.038

SO-VID: 075f195a-b614-4b39-902d-638589fe196f

License:

http://www.elsevier.com/tdm/userlicense/1.0/

History

Data availability:

Phase I trials of amonafide as monotherapy and in combination with cytarabine in patients with poor-risk acute myeloid leukemia

Read this article at

Related collections

IUCN Red List of Ecosystems

Author and article information

Journal

Article

History

Comments

Comment on this article

Similar content 1,853

Cited by 1